I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects
Pharmaceutical Co., Ltd. proposed biosimilar QL0605 compared to innovator product, US-Neulasta) in healthy, adult, human subjects.
- 0 views
- 27 Jan, 2021
- 2 locations
Vaccination With Flt3L Radiation and Poly-ICLC
blood cell growth factors (Neupogen or Neulasta) or red blood cell growth factors (EPO or Epogen) that you may have received to help protect your blood cells previously. Flt3L causes your body to make
tumor cells
chronic lymphocytic leukemia
growth factor
poly iclc
cancer
- 30 views
- 26 Oct, 2021
- 1 location